SCHEMBL4907164

SCHEMBL4907164

COc1cc(S(=O)(=O)C(F)F)ccc1N=C=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
CYP3A4 P08684 1/20 0.56
HPGD P15428 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
EPAS1 Q99814 6/20 0.37
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
PTGS1 P23219 2/20 0.35
PTGS2 P35354 2/20 0.35
KMT2A Q03164 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
VEGFA P15692 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4244349 0.89 ALDH1A1 (0.45) ALDH1A1CYP3A4HPGDTDP1SMN1; SMN2
SCHEMBL13556579 0.78 CYP3A4 (0.51) ALDH1A1CYP3A4HPGDTDP1EPAS1
SCHEMBL1943486 0.73 CYP3A4 (0.69) ALDH1A1CYP3A4HPGDTDP1SMN1; SMN2
SCHEMBL14992 0.73 CYP3A4 (1.00) ALDH1A1CYP3A4HPGDTDP1TSHR
SCHEMBL29350162 0.73 CYP3A4 (1.00) ALDH1A1CYP3A4HPGDTDP1TSHR
SCHEMBL13483626 0.72 EPAS1 (0.57) ALDH1A1SMN1; SMN2POLBTSHRMAPK1
SCHEMBL5252562 0.72 ALDH1A1 (0.71) ALDH1A1CYP3A4HPGDTDP1SMN1; SMN2
SCHEMBL543088 0.72 CYP3A4 (0.71) ALDH1A1CYP3A4HPGDTDP1TSHR
SCHEMBL29541267 0.72 ALDH1A1 (0.71) ALDH1A1CYP3A4HPGDTDP1SMN1; SMN2
SCHEMBL29800238 0.72 CYP3A4 (0.71) ALDH1A1CYP3A4HPGDTDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269265-A1 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas MILLER SCOTT 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269265-A1 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas BRAF, RAF1, MAP2K2 ALDH1A1 2032/4885CYP3A4 3074/4885HPGD 3567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.